ROCHESTER, MN / ACCESSWIRE / July 30, 2024 / Vista BioMedical™, Inc., a medical device and software development company, has launched VPAATH©, a pro-active, predictive AI-based program that can ...
IWK Health becomes first site in Nova Scotia to join Breathe BioMedical's multi-center study to advance development of its technology for early detection of breast cancer in womenMoncton, New Brunswic ...
CHASKA, Minn., Oct. 07, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract ...
Impact Biomedical Inc (NYSE: IBO) today announced that the Company's Board of Directors has approved a 1 for 12.62 reverse stock split of the Company's issued ...
HOUSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare ...
Lifecore Biomedical, Inc. ( LFCR) announced Monday that it has entered into a definitive agreement to be acquired by Webster Equity Partners in a transaction valued at up to $663.7 million, assuming ...
Impact Biomedical Inc. ( IBO) has issued a corrected update to its previously released merger announcement, clarifying that one Zoar Limited share for each Impact share held immediately prior to the ...
Lifecore Biomedical (Nasdaq: LFCR) closed up 55.24% at $6.52 on news it will be acquired by Webster Equity Partners for up to ...
Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results